Prapti Patel, M.D.
Listen to Dr. Prapti Patel's approach to patient care.
Effective April 8, 2022, Dr. Prapti Patel will be closing her practice at UT Southwestern Medical Center. The clinic will be happy to recommend a physician to assume your care. Patients can obtain a copy of their medical records by calling 214-645-3030 or by email at
medical.records@utsouthwestern.edu
Prapti Patel, M.D., is an Associate Professor in UT Southwestern Medical Center's Department of Internal Medicine. She specializes in the treatment of leukemia, lymphoma, and myelodysplasia, and in providing bone marrow and stem cell transplants for those patients.
Dr. Patel earned her medical degree from Creighton University. After her residency in internal medicine at Washington University/Barnes-Jewish Hospital, she completed a fellowship in hematology/oncology at UT Southwestern, in which she served as the chief hematology/oncology fellow. She joined the faculty of UT Southwestern in 2011.
In addition to her clinical work, Dr. Patel engages in research to improve understanding of malignant hematology and bone marrow transplant. Her research interests include acute myeloid leukemia (AML), allogeneic transplant, and sickle cell disease.
She is board certified in hematology and medical oncology by the American Board of Internal Medicine.
In 2019 and 2020, Dr. Patel was named a Texas Monthly Super Doctor Rising Star.
The path to health for patients with leukemia, lymphoma, and myelodysplasia can be complex. Bone marrow transplant specialist Prapti Patel, M.D., emphasizes a close working relationship with her patients to make the experience easier.
“The treatments for these diseases can be difficult for patients – they require multiple visits and patients may experience side effects, ” Dr. Patel says. “But working together, we can navigate through the experience and improve their quality of life.”
Care for these complicated diseases requires a team approach, and UT Southwestern Medical Center excels at providing coordinated care among several experts focused on different areas.
As part of UT Southwestern's Bone Marrow Transplant and Hematologic Malignancies Program in Dallas, Dr. Patel offers expertise that comes from focusing solely on malignant hematologies such as leukemia.
The program, which has received acclaim for excellent clinical results, with outcomes superior to national norms in several areas, is a recognized leader in laboratory and clinical research.
“Our team approach to the treatment of these complex diseases helps give patients a second chance at life," she says.
Dr. Patel leads UT Southwestern's Sickle Cell Transplant Program, which began in July 2013. UT Southwestern is one of just a few academic medical centers offering this treatment option. Stem cell transplants for sickle cell patients can help end a lifetime of pain and hospitalizations.
In addition to her clinical work, Dr. Patel researches various malignant hematology areas, including new drugs for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).